Shares of Inovio Pharmaceuticals fell by a staggering 39.82% in 30 days from $10.85 to $6.53 at 20:39 EST on Tuesday, after five consecutive sessions in a row of losses. NASDAQ Composite is sliding 1.88% to $13,633.50, after three successive sessions in a row of losses.

Inovio Pharmaceuticals’s last close was $6.65, 417.46% below its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is a negative 35.9% for the ongoing quarter and 237.1% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.8% and 77.1%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $6.53 at 20:39 EST, way below its 52-week high of $33.79 and above its 52-week low of $6.33.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is way under its 50-day moving average of $10.61 and way below its 200-day moving average of $11.28.

More news about Inovio Pharmaceuticals.

LEAVE A REPLY

Please enter your comment!
Please enter your name here